Characteristic | N(%) | Consistent gel usersn(%) | uOR (95% CI) | LRTPvalue | Age aOR (95% CI) | LRTPvalue |
---|---|---|---|---|---|---|
All participants | 544 (100) | 369 (67.8) | Â | Â | Â | Â |
Age group | Â | Â | Â | Â | Â | Â |
17– 24 | 92 (16.9) | 44 (47.8) | 1 | <0.01 | N/A |  |
25–34 | 237 (43.6) | 172 (72.6) | 2.9 (1.8–4.8) |  |  |  |
≥35 | 215 (39.5) | 153 (71.2) | 2.7 (1.6–4.5) |  |  |  |
Religion | Â | Â | Â | Â | Â | Â |
Christian | 472 (86.8) | 319 (67.6) | 1 | 0.75 | 1 | 0.54 |
Muslim | 72 (13.2) | 50 (69.4) | 1.1 (0.6–1.9) |  | 1.2 (0.7–2.1) |  |
Level of education | Â | Â | Â | Â | Â | Â |
None | 81 (14.9) | 54 (66.7) | 1 | 0.81 | 1 | 0.52 |
Some education | 463 (85.1) | 315 (68.0) | 1.1 (0.6–1.8) |  | 1.2 (0.7–2.0) |  |
Employment status | Â | Â | Â | Â | Â | Â |
Employed | 92 (16.9) | 55 (59.8) | 1 | 0.07 | 1 | 0.11 |
Unemployed | 452 (83.1) | 314 (69.5) | 1.5 (1.0–2.4) |  | 1.5 (0.9–2.4) |  |
Family planning use | Â | Â | Â | Â | Â | Â |
No | 227 (41.7) | 155 (68.3) | 1 | 0.85 | 1 | 0.86 |
Yes | 317 (58.3) | 214 (67.5) | 0.9 (0.7–1.4) |  | 1.0 (0.7–1.4) |  |
Condom use | Â | Â | Â | Â | Â | Â |
No | 190 (34.9) | 123 (64.7) | 1 | 0.26 | 1 | 0.41 |
Yes | 354 (65.1) | 246 (69.5) | 1.2 (0.9–1.8) |  | 1.2 (0.8–1.7) |  |
Perceived sexual experience using gel | Â | Â | Â | Â | Â | Â |
Gel made sex less enjoyable | 41 (7.5) | 26 (63.4) | 1 | 0.48 | 1 | 0.27 |
Gel left sexual pleasure the same | 317 (58.3) | 209 (65.9) | 1.1 (0.6–2.2) |  | 1.2 (0.6–2.4) |  |
Gel made sex more enjoyable | 186 (34.2) | 134 (72.0) | 1.5 (0.7–3.2) |  | 1.6 (0.8–3.4) |  |
Pregnancy status | Â | Â | Â | Â | Â | Â |
Positive | 90 (16.5) | 57 (63.3) | 1 | 0.32 | 1 | 0.11 |
Negative | 454 (83.5) | 312 (68.7) | 1.3 (0.8–2.0) |  | 1.5 (0.9–2.5) |  |
Rooms used for sleeping in at home | Â | Â | Â | Â | Â | Â |
One | 187 (34.4) | 111 (59.4) | 1 | 0.02 | 1 | 0.03 |
Two | 177 (32.5) | 120 (67.8) | 1.4 (0.9–2.2) |  | 1.2 (0.8–1.9) |  |
Three+ | 180 (33.1) | 138 (76.7) | 2.2 (1.4–3.5) |  | 1.9 (1.2–3.1) |  |
Trial arm | Â | Â | Â | Â | Â | Â |
Placebo | 275 (50.6) | 183 (66.6) | 1 | 0.52 | 1 | 0.58 |
PRO2000 (0.5%) | 269 (49.4) | 186 (69.1) | 1.1 (0.8–1.6) |  | 1.1 (0.8–1.6) |  |